OMADA HEALTH INC (OMDA) Fundamental Analysis & Valuation

NASDAQ:OMDA • US68170A1088

Current stock price

14.73 USD
+0.4 (+2.79%)
Last:

This OMDA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

2

1. OMDA Profitability Analysis

1.1 Basic Checks

  • In the past year OMDA has reported negative net income.
  • In the past year OMDA had a positive cash flow from operations.
OMDA Yearly Net Income VS EBIT VS OCF VS FCFOMDA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 2024 2025 0 -20M -40M -60M

1.2 Ratios

  • Looking at the Return On Assets, with a value of -4.18%, OMDA is doing worse than 66.00% of the companies in the same industry.
  • The Return On Equity of OMDA (-5.56%) is comparable to the rest of the industry.
Industry RankSector Rank
ROA -4.18%
ROE -5.56%
ROIC N/A
ROA(3y)-24.66%
ROA(5y)N/A
ROE(3y)-48.91%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
OMDA Yearly ROA, ROE, ROICOMDA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 2024 2025 -20 -40 -60

1.3 Margins

  • OMDA has a Gross Margin of 65.69%. This is amongst the best in the industry. OMDA outperforms 85.00% of its industry peers.
  • OMDA's Gross Margin has improved in the last couple of years.
  • OMDA does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 65.69%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y11.04%
GM growth 5YN/A
OMDA Yearly Profit, Operating, Gross MarginsOMDA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 2024 2025 0 50 -50

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

8

2. OMDA Health Analysis

2.1 Basic Checks

  • OMDA does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, OMDA has more shares outstanding
  • There is no outstanding debt for OMDA. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
OMDA Yearly Shares OutstandingOMDA Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 2025 10M 20M 30M 40M 50M
OMDA Yearly Total Debt VS Total AssetsOMDA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 2025 100M 200M 300M

2.2 Solvency

  • OMDA has an Altman-Z score of 6.09. This indicates that OMDA is financially healthy and has little risk of bankruptcy at the moment.
  • With an excellent Altman-Z score value of 6.09, OMDA belongs to the best of the industry, outperforming 91.00% of the companies in the same industry.
  • OMDA has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 6.09
ROIC/WACCN/A
WACC9.02%
OMDA Yearly LT Debt VS Equity VS FCFOMDA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 2025 0 100M 200M

2.3 Liquidity

  • A Current Ratio of 3.60 indicates that OMDA has no problem at all paying its short term obligations.
  • OMDA's Current ratio of 3.60 is amongst the best of the industry. OMDA outperforms 87.00% of its industry peers.
  • OMDA has a Quick Ratio of 3.54. This indicates that OMDA is financially healthy and has no problem in meeting its short term obligations.
  • OMDA has a Quick ratio of 3.54. This is amongst the best in the industry. OMDA outperforms 88.00% of its industry peers.
Industry RankSector Rank
Current Ratio 3.6
Quick Ratio 3.54
OMDA Yearly Current Assets VS Current LiabilitesOMDA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 2025 50M 100M 150M 200M 250M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. OMDA Growth Analysis

3.1 Past

  • OMDA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 58.75%, which is quite impressive.
  • Looking at the last year, OMDA shows a very strong growth in Revenue. The Revenue has grown by 53.24%.
  • The Revenue has been growing by 42.89% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)58.75%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%110.47%
Revenue 1Y (TTM)53.24%
Revenue growth 3Y42.89%
Revenue growth 5YN/A
Sales Q2Q%-55.33%

3.2 Future

  • The Earnings Per Share is expected to grow by 62.39% on average over the next years. This is a very strong growth
  • OMDA is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 17.85% yearly.
EPS Next Y123.35%
EPS Next 2Y71.44%
EPS Next 3Y62.39%
EPS Next 5YN/A
Revenue Next Year25.59%
Revenue Next 2Y22.8%
Revenue Next 3Y21.17%
Revenue Next 5Y17.85%

3.3 Evolution

  • Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
OMDA Yearly Revenue VS EstimatesOMDA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 2025 2026 2027 2028 2029 2030 100M 200M 300M 400M 500M
OMDA Yearly EPS VS EstimatesOMDA Yearly EPS VS EstimatesYearly EPS VS Estimates 2025 2026 2027 2028 0 0.2 -0.2 0.4

More info and screens

Find the best growth stocksShow best growing peers

1

4. OMDA Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for OMDA. In the last year negative earnings were reported.
  • A Price/Forward Earnings ratio of 242.02 indicates a quite expensive valuation of OMDA.
  • 67.00% of the companies in the same industry are cheaper than OMDA, based on the Price/Forward Earnings ratio.
  • When comparing the Price/Forward Earnings ratio of OMDA to the average of the S&P500 Index (22.29), we can say OMDA is valued expensively.
Industry RankSector Rank
PE N/A
Fwd PE 242.02
OMDA Price Earnings VS Forward Price EarningsOMDA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 100 200

4.2 Price Multiples

  • OMDA's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 69.89
EV/EBITDA N/A
OMDA Per share dataOMDA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3 4

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
  • A more expensive valuation may be justified as OMDA's earnings are expected to grow with 62.39% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y71.44%
EPS Next 3Y62.39%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. OMDA Dividend Analysis

5.1 Amount

  • No dividends for OMDA!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

OMDA Fundamentals: All Metrics, Ratios and Statistics

OMADA HEALTH INC

NASDAQ:OMDA (4/27/2026, 12:52:23 PM)

14.73

+0.4 (+2.79%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)03-05
Earnings (Next)05-07
Inst Owners72.16%
Inst Owner Change5.17%
Ins Owners7.37%
Ins Owner Change15.05%
Market Cap868.04M
Revenue(TTM)260.21M
Net Income(TTM)-12.78M
Analysts78.82
Price Target22.24 (50.98%)
Short Float %7.64%
Short Ratio2.51
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)137.95%
Min EPS beat(2)22.85%
Max EPS beat(2)253.04%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)8.02%
Min Revenue beat(2)6.73%
Max Revenue beat(2)9.3%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-17.88%
PT rev (3m)-18.71%
EPS NQ rev (1m)0%
EPS NQ rev (3m)6.67%
EPS NY rev (1m)192.6%
EPS NY rev (3m)276.8%
Revenue NQ rev (1m)-0.03%
Revenue NQ rev (3m)3.61%
Revenue NY rev (1m)0.02%
Revenue NY rev (3m)2.37%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 242.02
P/S 3.34
P/FCF 69.89
P/OCF 47.56
P/B 3.78
P/tB 4.06
EV/EBITDA N/A
EPS(TTM)-0.23
EYN/A
EPS(NY)0.06
Fwd EY0.41%
FCF(TTM)0.21
FCFY1.43%
OCF(TTM)0.31
OCFY2.1%
SpS4.42
BVpS3.9
TBVpS3.63
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -4.18%
ROE -5.56%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 65.69%
FCFM 4.77%
ROA(3y)-24.66%
ROA(5y)N/A
ROE(3y)-48.91%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y11.04%
GM growth 5YN/A
F-Score6
Asset Turnover0.85
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA N/A
Cap/Depr 106.21%
Cap/Sales 2.24%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.6
Quick Ratio 3.54
Altman-Z 6.09
F-Score6
WACC9.02%
ROIC/WACCN/A
Cap/Depr(3y)84.1%
Cap/Depr(5y)N/A
Cap/Sales(3y)2.3%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)58.75%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%110.47%
EPS Next Y123.35%
EPS Next 2Y71.44%
EPS Next 3Y62.39%
EPS Next 5YN/A
Revenue 1Y (TTM)53.24%
Revenue growth 3Y42.89%
Revenue growth 5YN/A
Sales Q2Q%-55.33%
Revenue Next Year25.59%
Revenue Next 2Y22.8%
Revenue Next 3Y21.17%
Revenue Next 5Y17.85%
EBIT growth 1Y72.58%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year175.83%
EBIT Next 3Y62.18%
EBIT Next 5Y39.74%
FCF growth 1Y132.65%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y153.4%
OCF growth 3YN/A
OCF growth 5YN/A

OMADA HEALTH INC / OMDA Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for OMADA HEALTH INC?

ChartMill assigns a fundamental rating of 4 / 10 to OMDA.


Can you provide the valuation status for OMADA HEALTH INC?

ChartMill assigns a valuation rating of 1 / 10 to OMADA HEALTH INC (OMDA). This can be considered as Overvalued.


What is the profitability of OMDA stock?

OMADA HEALTH INC (OMDA) has a profitability rating of 2 / 10.


What is the financial health of OMADA HEALTH INC (OMDA) stock?

The financial health rating of OMADA HEALTH INC (OMDA) is 8 / 10.